AR077244A1 - Composicion farmaceutica que comprende poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxipropano ) - Google Patents

Composicion farmaceutica que comprende poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxipropano )

Info

Publication number
AR077244A1
AR077244A1 ARP100102272A ARP100102272A AR077244A1 AR 077244 A1 AR077244 A1 AR 077244A1 AR P100102272 A ARP100102272 A AR P100102272A AR P100102272 A ARP100102272 A AR P100102272A AR 077244 A1 AR077244 A1 AR 077244A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
hydroxipropane
dialil
alilamin
poli
Prior art date
Application number
ARP100102272A
Other languages
English (en)
Inventor
Perez Sergio Lloret
Guasch Laura Diaz
Original Assignee
Combino Pharm Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combino Pharm Sl filed Critical Combino Pharm Sl
Priority to PCT/EP2010/059149 priority Critical patent/WO2010149794A2/en
Publication of AR077244A1 publication Critical patent/AR077244A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Una composicion farmacéutica solida para administracion oral que comprende de aproximadamente el 80% a aproximadamente el 94% en peso de sevelámero, incluyendo el agua de hidratacion, y al menos un excipiente farmacéuticamente aceptable.
ARP100102272A 2009-06-26 2010-06-25 Composicion farmaceutica que comprende poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxipropano ) AR077244A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2010/059149 WO2010149794A2 (en) 2009-06-26 2010-06-28 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200930368A ES2350999B1 (es) 2009-06-26 2009-06-26 Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
PCT/EP2009/058122 WO2010149230A1 (en) 2009-06-26 2009-06-29 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) hydrochloride

Publications (1)

Publication Number Publication Date
AR077244A1 true AR077244A1 (es) 2011-08-10

Family

ID=41728227

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100102272A AR077244A1 (es) 2009-06-26 2010-06-25 Composicion farmaceutica que comprende poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxipropano )

Country Status (4)

Country Link
AR (1) AR077244A1 (es)
CL (1) CL2012000375A1 (es)
ES (1) ES2350999B1 (es)
WO (1) WO2010149230A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108338975A (zh) * 2017-01-25 2018-07-31 北京泰德制药股份有限公司 一种含有司维拉姆或其药用盐的组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CZ20021344A3 (cs) * 1999-10-19 2002-08-14 Geltex Pharmaceuticals, Inc. Tableta obsahující jádro a potahování a stlačená tableta
CA2642255A1 (en) * 2006-02-14 2007-08-23 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
CA2661987C (en) * 2006-09-01 2012-11-06 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer

Also Published As

Publication number Publication date
CL2012000375A1 (es) 2012-07-27
ES2350999B1 (es) 2011-12-07
ES2350999A1 (es) 2011-01-28
WO2010149230A1 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
CR20110435A (es) Formulaciones de 4-amino-2-(2,6-dioxopiperidina-3-il) isoindolina-1,3-diona
AR089578A1 (es) Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
UY32490A (es) Inhibidores de beta-secretasa
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
UY35624A (es) Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington
GT201200126A (es) Derivados de la cromenona con actividad anti-tumoral
CO6470847A2 (es) Derivados amino-propiónicos sustituidos como inhibidores de neprilisina
ECSP11011561A (es) Derivados aminobutíricos sustituidos como inhibidores de neprilisina
MA32812B1 (fr) Composition pharmaceutique d'un inhibiteur puissant du vhc pour une administration orale
PE20120713A1 (es) Composiciones sublinguales de dexmedetomidina y metodos para su uso
ECSP12011958A (es) Composiciones farmacéuticas que comprenden ligandos de receptores sigma
EA201071039A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
ECSP13012812A (es) Formulaciones inmunosupresoras
TN2015000135A1 (en) Modified release formulations for oprozomib
CR20110704A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
CO6612185A2 (es) Composiciones famacéuticas para el tratamiento del cáncer y otras enfermedades o transtornos
CO6351721A2 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
ECSP10010553A (es) Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre
CO6640318A2 (es) Formas de dosificación oral de bendamustina
BR112012013199A2 (pt) composto, composição farmacêutica, e , uso de um composto
AR080256A1 (es) Formulaciones farmaceuticas solidas de ramipril y besilato de amlodipino y su preparacion
AR077244A1 (es) Composicion farmaceutica que comprende poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxipropano )

Legal Events

Date Code Title Description
FB Suspension of granting procedure